Background
Methods
Study design and population
Cardiovascular magnetic resonance
Statistical analysis
All patients (n = 792) | Hypertension (n = 540) | No hypertension (n = 252) |
p value | |
---|---|---|---|---|
Age, years | 62 [51–71] | 66 [55–73] | 54 [48–63] | <0.001 |
Male sex, n (%) | 600 (76) | 389 (72) | 211 (84) | <0.001 |
Body mass index, kg/m2
| 27 [25–30] | 28 [25–31] | 26 [24–29] | <0.001 |
Cardiovascular risk factors | ||||
Current smoking, n (%) | 339/724 (43) | 194/482 (36) | 145/242 (58) | <0.001 |
Diabetes mellitus, n (%) | 160/789 (20) | 142/539 (26) | 18/250 (7) | <0.001 |
Hypercholesterolemia, n (%) | 303/784 (38) | 250/536 (46) | 53/250 (21) | <0.001 |
Family history for CAD, n (%) | 268/611 (34) | 177/407 (33) | 91/204 (36) | 0.79 |
Systolic blood pressure, mmHg | 130 [117–147] | 135 [119–150] | 126 [114–140] | <0.001 |
Diastolic blood pressure, mmHg | 80 [70–88] | 80 [70–90] | 80 [70–85] | 0.07 |
Heart rate, beats/min | 76 [67–87] | 76 [68–88] | 76 [65–85] | 0.23 |
Time from symptom onset to PCI hospital admission, min | 180 [109–310] | 183 [110–311] | 166 [104–306] | 0.23 |
Door-to-balloon time, min | 30 [22–42] | 30 [23–42] | 29 [20–42] | 0.56 |
Previous infarction, n (%) | 48/791 (6) | 42/539 (8) | 6/631 (2) | <0.01 |
Previous PPCI, n (%) | 67 (9) | 61 (11) | 6 (2) | <0.001 |
Previous CABG, n (%) | 11 (1) | 11 (2) | 0 (0) | 0.02 |
Anterior infarction, n (%) | 395/755 (50) | 262/516 (49) | 133/239 (53) | 0.21 |
Killip-class on admission | 0.52 | |||
1, n (%) | 696 (88) | 472 (87) | 224 (89) | |
2, n (%) | 59 (7) | 42 (8) | 17 (7) | |
3, n (%) | 20 (3) | 16 (3) | 4 (2) | |
4, n (%) | 17 (2) | 10 (2) | 7 (3) | |
Number of diseased vessels | <0.01 | |||
1, n (%) | 419 (53) | 261 (48) | 158 (63) | |
2, n (%) | 225 (28) | 165 (31) | 60 (24) | |
3, n (%) | 148 (19) | 114 (21) | 34 (14) | |
Infarct related artery | 0.59 | |||
Left anterior descending, n (%) | 344 (43) | 240 (44) | 104 (41) | |
Right coronary artery, n (%) | 344 (43) | 226 (42) | 118 (47) | |
Left circumflex, n (%) | 97 (12) | 68 (13) | 29 (12) | |
Left main, n (%) | 5 (1) | 4 (1) | 1 (0) | |
Bypass graft, n (%) | 2 (0) | 2 (0) | 0 (0) | |
TIMI risk score | 3 [2–5] | 4 [2–5] | 2 [2–4] | <0.001 |
TIMI-flow before PPCI | 0.64 | |||
TIMI-flow 0, n (%) | 444 (56) | 298 (55) | 146 (58) | |
TIMI-flow 1, n (%) | 103 (13) | 73 (14) | 30 (12) | |
TIMI-flow 2, n (%) | 128 (16) | 92 (17) | 36 (14) | |
TIMI-flow 3, n (%) | 117 (15) | 77 (14) | 40 (16) | |
TIMI-flow after PPCI | 0.38 | |||
TIMI-flow 0, n (%) | 12 (2) | 9 (2) | 3 (1) | |
TIMI-flow 1, n (%) | 19 (2) | 14 (3) | 5 (2) | |
TIMI-flow 2, n (%) | 61 (8) | 47 (9) | 14 (6) | |
TIMI-flow 3, n (%) | 699 (88) | 469 (87) | 230 (91) | |
Stent implanted, n (%) | 774 (98) | 527 (98) | 247 (98) | 0.60 |
Thrombectomy, n (%) | 190 (24) | 124 (23) | 66 (26) | 0.32 |
Concomitant medications | ||||
Aspirin, n (%) | 790 (100) | 538 (100) | 252 (100) | 1.0 |
ß-blockers, n (%) | 757 (96) | 519 (96) | 238 (94) | 0.19 |
ACE-I/ARB, n (%) | 751 (95) | 515 (95) | 236 (94) | 0.21 |
Statin, n (%) | 749 (95) | 508 (94) | 241 (96) | 0.47 |
Aldosterone antagonist, n (%) | 80 (10) | 55 (12) | 25 (10) | 0.34 |
Results
Study population
Antecedent hypertension and clinical outcome
All patients (n = 792) | Hypertension (n = 540) | No hypertension (n = 252) |
p value | |
---|---|---|---|---|
MACE, n (%) | 53 (7) | 45 (8) | 8 (3) | <0.01 |
Death, n (%) | 22 (3) | 20 (4) | 2 (1) | 0.02 |
Re-infarction, n (%) | 21 (3) | 16 (3) | 5 (2) | 0.42 |
Heart failure event, n (%) | 25 (3) | 21 (4) | 4 (2) | 0.08 |
Univariate | Multivariate | |||
---|---|---|---|---|
HR (95 % CI) |
p value | HR (95 % CI) |
p value | |
Age, >median | 2.49 [1.38–4.47] | <0.01 | - | - |
Gender, 1 female | 1.95 [1.12–3.40] | 0.02 | - | - |
Smoking status, 1 yes | 0.46 [0.24–0.87] | 0.02 | - | - |
Diabetes mellitus, 1 yes | 1.91 [1.07–3.41] | 0.03 | - | - |
Hypertension, 1 yes | 2.70 [1.27–5.72] | 0.01 | 3.42 [1.45–8.08] | <0.01 |
Heart rate, >median | 1.96 [1.12–3.43] | 0.02 | - | - |
Killip-class, I-IV | 1.90 [1.46–2.48] | <0.001 | 1.91 [1.40–2.60] | <0.001 |
Vessel Disease, I-III | 1.34 [1.01–1.78] | 0.04 | - | - |
Antecedent hypertension and cardiovascular magnetic resonance findings
All patients (n = 792) | Hypertension (n = 540) | No hypertension (n = 252) |
p value | |
---|---|---|---|---|
Area at risk, % LV | 35 [25–48] | 34 [25–47] | 37 [26–49] | 0.18 |
Infarct size, % LV | 16.7 [8.5–24.9] | 16.9 [8.8–24.8] | 16.6 [8.3–25.0] | 0.74 |
Presence of microvascular obstruction, n (%) | 400 (51) | 274 (51) | 126 (50) | 0.85 |
Extent of microvascular obstruction, % LV | 0 [0–1.8] | 0 [0.0–1.6] | 0 [0.0–2.0] | 0.93 |
Myocardial salvage index, % area at risk | 51 [33–69] | 50 [33–67] | 54 [32–72] | 0.20 |
LV ejection fraction, % | 50 [43–58] | 50 [43–58] | 51 [44–58] | 0.47 |
LV myocardial mass, g | 132 [109–156] | 134 [111–158] | 131 [109–155] | 0.38 |